LISA WALLACE: Open Payments
NPI 1134438286 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 10 payments from 7 companies in 2025. Trend: 2023 $590 · 2024 $173 · 2025 $279
Food & beverage: $184Education: $95
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $109 |
| Novo Nordisk Inc | 3 | $53 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Abbott Laboratories | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| BeOne Medicines USA, Inc. | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
Products named: Enhertu, Ozempic, Stimufend, CARDIOMEMS, VYNDAQEL, BRUKINSA, Rybelsus, LifeVest.
Industry payments across IN — which companies pay providers there.
